Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 11:46:52 2024-04-17 am EDT			5-day change	1st Jan Change
0.02 ^USD	-33.33%		0.00%	-82.76%

Mar. 06	Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 12, 2022 at 02:48 pm EDT

H-CYTE, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.0739 million compared to USD 0.450456 million a year ago. Net loss was USD 2.64 million compared to USD 2.06 million a year ago. Basic loss per share from continuing operations was USD 11.97 compared to USD 14.90 a year ago. Diluted loss per share from continuing operations was USD 11.97 compared to USD 14.90 a year ago.
For the six months, sales was USD 0.45346 million compared to USD 0.826625 million a year ago. Net loss was USD 6.53 million compared to USD 3.47 million a year ago. Basic loss per share from continuing operations was USD 29.87 compared to USD 25.52 a year ago. Diluted loss per share from continuing operations was USD 29.87 compared to USD 25.52 a year ago.

Latest news about Innoveren Scientific Inc.

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	Mar. 06	CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 15	CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	23-07-10	CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	23-07-10	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-10	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	23-05-09	CI
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	23-04-11	CI
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	23-02-23	CI
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	22-12-28	CI
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
H-CYTE, Inc. announced that it has received $0.225 million in funding	22-09-28	CI
H-CYTE, Inc. (OTCQB: HCYT) entered into a letter of intent to acquire SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown for $2.3 million.	22-09-18	CI
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc.	22-09-07	CI
H-CYTE, Inc. acquired Jantibody, LLC.	22-09-07	CI
H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
H-Cyte, Inc. Closes Its Clinic in Scottsdale, Arizona	22-06-09	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
H-CYTE, Inc. Moves its Headquarters	22-04-04	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	22-02-24	CI
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors	22-01-14	CI
H-CYTE, Inc. entered into a letter of intent to acquire Catheter Precision, Inc.	22-01-10	CI
H-CYTE, Inc. Announces Resignation of Tanya Rhodes as Interim Chief Executive Officer	21-12-07	CI

Chart Innoveren Scientific Inc.

Duration

Period

More charts

Company Profile

Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INNOVEREN SCIENTIFIC INC.	-82.76%	107K
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology